Literature DB >> 7000893

Characterization of mouse helper and suppressor T cell subsets separated by lectins.

T Nakano, Y Imai, M Naiki, T Osawa.   

Abstract

Concanavalin A (Con A)-activated cells were fractionated by separating cells that agglutinate with peanut agglutinin (PNA) which binds preferentially to the sugar sequence beta-D-Gal-(1 leads to 3)-D-GalNAc. PNA-agglutinable cells were found to exert a significant suppressor effect on the primary antibody response to sheep red blood cells, whereas PNA-nonagglutinable cells did not affect the antibody response. It was also found that PNA-agglutinable suppressor cells were sensitive to treatment with anti-Thy 1.2 and complement (C), anti-I-J antiserum and complement, and anti-Ly 2.2 antiserum and complement. These results suggest that the PNA-agglutinable suppressor cells, separated from Con A-activated cells, were T cells and that these suppressor T cells possess abundant beta-galactosyl residues exposed on the cell surface, not masked by sialyl residues. Furthermore, it was found that antigen-specific suppressor cells were also separable by use of the agglutinability with PNA. The PNA-agglutinable suppressor T cell activity was eliminated by treatment of the Con A-activated PNA-agglutinable cells with anti-asialo GM1 and complement, anti-Forssman antiserum and complement, and anti-globoside antiserum and complement, but not by treatment with anti-GM1 antiserum and complement. Conversely, the helper T cell activity that was induced by Lens culinalis agglutinin and separated by Limulus polyphemus agglutinin, was eliminated by treatment of the cells with anti-GM1 and complement, but not by the treatment with the other anti-glycolipid antisera and complement.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000893

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  The in vitro generation of suppressor lymphocytes involves interactions between PNA+ and PNA- thymocyte populations.

Authors:  A Eisenthal; D Nachitgal; M Feldman
Journal:  Immunology       Date:  1982-08       Impact factor: 7.397

2.  Separation of concanavalin A-induced human suppressor and helper T cells by the autologous erythrocyte rosette technique.

Authors:  T Sakane; M Honda; Y Taniguchi; H Kotani
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

3.  Analysis of autoantibodies to glycolipids on thymocytes in New Zealand black mice.

Authors:  N Ishii; K Watanabe
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

4.  Experimental studies of immunologically mediated enteropathy. II. Role of natural killer cells in the intestinal phase of murine graft-versus-host reaction.

Authors:  A M Mowat; M V Felstein
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

5.  Sialidase activity and antibodies to sialidase-treated autologous erythrocytes in bronchoalveolar lavages from patients with idiopathic pulmonary fibrosis or sarcoidosis.

Authors:  C R Lambré; Y Pilatte; S Le Maho; A Greffard; H De Crémoux; J Bignon
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

6.  Lymphocyte subpopulations in the thymus of NZB x NZW mice: phenotypic characterization by flow cytofluorometry analysis.

Authors:  F Dumont; R C Habbersett
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

7.  Studies of immune functions of patients with systemic lupus erythematosus: antibodies to desialized, rather than intact, T cells preferentially bind to and eliminate suppressor effector T cells.

Authors:  M Honda; T Sakane; A D Steinberg; H Kotani; T Tsunematsu; K Moriyama; M Fukase
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

8.  Immunoregulation in experimental filariasis. III. Demonstration and characterization of antigen-specific suppressor cells in the spleen of Brugia pahangi-infected jirds.

Authors:  P J Lammie; S P Katz
Journal:  Immunology       Date:  1984-06       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.